Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Julian Stanley Kroin is active.

Publication


Featured researches published by Julian Stanley Kroin.


Synthetic Communications | 1991

Preparation and Storage of (R)-2,3-O-Isopropylideneglyceraldehyde (D-Glyceraldehyde Acetonide)

Larry Wayne Hertel; Cora Sue Grossman; Julian Stanley Kroin

Abstract This is a report on the synthesis and on the storage of D-glyceraldehyde acetonide for as long as three years after initial preparation while retaining its enantiomeric purity.


Bioorganic & Medicinal Chemistry Letters | 1999

Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146.

Bryan H. Norman; Anne H. Dantzig; Julian Stanley Kroin; Kevin L. Law; Linda B. Tabas; Robert L. Shepard; Alan David Palkowitz; Kenneth Lee Hauser; Mark Alan Winter; James P. Sluka; James J. Starling

The benzothiophene LY329146 reverses the drug resistance phenotype in multidrug resistance protein (MRP1)-overexpressing cells when dosed in combination with MRP1-associated oncolytics doxorubicin and vincristine. Additionally, LY329146 inhibited MRP1-mediated uptake of the MRP1 substrate LTC4 into membrane vesicles prepared from MRP1-overexpressing cells.


Tetrahedron Letters | 1995

Stereoselective synthesis of novel methylene ether dipeptide isosteres

Bryan H. Norman; Julian Stanley Kroin

Abstract We have developed a versatile new synthesis of the Ψ[CH 2 O] pseudopeptides from N -protected 5-substituted morpholin-3-ones. This approach focuses on a stereoselective alkylation of the morpholin-3-ones. The resulting alkylation products were used in the synthesis of some previously unavailable Ψ[CH 2 O] dipeptides.


Advances in Enzyme Regulation | 1997

Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein

James J. Starling; Robert L. Shepard; Jin Cao; Kevin L. Law; Bryan H. Norman; Julian Stanley Kroin; William J. Ehlhardt; Todd M. Baughman; Mark Alan Winter; Michael Gregory Bell; Chuan Shih; Joseph Michael Gruber; William F. Elmquist; Anne H. Dantzig


Bioorganic & Medicinal Chemistry Letters | 2005

Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1).

Bryan H. Norman; Peter Ambrose Lander; Joseph Michael Gruber; Julian Stanley Kroin; Jeffrey Daniel Cohen; Louis Nickolaus Jungheim; James J. Starling; Kevin L. Law; Tracy D. Self; Linda B. Tabas; Daniel C. Williams; Donald C. Paul; Anne H. Dantzig


Archive | 1989

2',3'-Dideoxy-2',2'-difluoronucleosides

Larry Wayne Hertel; Cora Sue Grossman; Julian Stanley Kroin


Nucleic Acids Research | 1992

Synthesis and restriction enzyme analysis of oligodeoxyribonucleotides containing the anti-cancer drug 2', 2' -difluoro-2'-deoxycytidine

Frank C. Richardson; Katherine K. Richardson; Julian Stanley Kroin; Larry Wayne Hertel


Archive | 1993

2'-deoxy-2', 2'-difluoro(4-substituted pyrimidine) nucleosides having antiviral and anti-cancer activity and intermediates

Larry Wayne Hertel; Julian Stanley Kroin


Cancer Research | 1993

Effect of a Template-located 2′,2′-Difluorodeoxycytidine on the Kinetics and Fidelity of Base Insertion by Klenow (3′→5′Exonuclease-) Fragment

William E. Schy; Larry Wayne Hertel; Julian Stanley Kroin; Linda B. Bloom; Myron F. Goodman; Frank C. Richardson


Journal of Organic Chemistry | 1996

Alkylation Studies of N-Protected-5-substituted Morpholin-3-ones. A Stereoselective Approach to Novel Methylene Ether Dipeptide Isosteres

Bryan H. Norman; Julian Stanley Kroin

Collaboration


Dive into the Julian Stanley Kroin's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge